


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
IMMX
Immix Biopharma Inc.
$8.15
Strengths

Upgraded on attractively valued

Outperform the market
IMMX Price Performance
$6.12 (+33.17%)
$5.56 (+46.58%)
$2.54 (+220.87%)
$1.82 (+347.80%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
IMMX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IMMX Street Sentiment is extremely bullish and have negative views on the near-term outlook
IMMX has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 09, 2026
Initiate
Outperform
Mizuho
What is IMMX current stock price?
What are IMMX stock strengths?
What is IMMX Risk Level?
What is IMMX market cap and volume?
What is IMMX current Stock IQ?
Should I buy IMMX stock right now?
Is IMMX a Strong Buy right now?
What does a 'Strong Buy' rating mean for IMMX?
What does a 'Strong Sell' rating mean for IMMX?
What factors influence IMMX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
IMMX
Immix Biopharma Inc.
Current Price
$8.15

IMMX Price Performance
$6.12 (+33.17%)
$5.56 (+46.58%)
$2.54 (+220.87%)
$1.82 (+347.80%)
IMMX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
IMMX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IMMX Street Sentiment is extremely bullish and have negative views on the near-term outlook
IMMX has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
IMMX Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
IMMX Latest Analysis
Immix Biopharma to Participate in Upcoming Investor Conferences. LOS ANGELES CA March 03 2026 (GLOBE NEWSWIRE) -- Immix Biopharma Inc. (ImmixBio Company We or Us or IMMX) the global leader in relapsed/refractory AL Amyloidosis today announced that it will present and host investor meetings at the following upcoming institutional investor conferences:
Tue Mar 3, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IMMX Stock trends
IMMX Stock performance
IMMX Stock analysis
IMMX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.